Health News & Press Release Distribution

Health

APAC
Global

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

SHUZHOU, China, Jan. 2, 2020 /PRNewswire/ -- CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participati...

2020-01-02 08:00 4912

CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

Panzhihua, China: Creating a New Benchmark for the Recuperation and Health Preservation Industry

CHENGDU, China, Dec. 31, 2019 /PRNewswire/ -- In December 2019, the 10th Panzhihua Joy and Sunshine Festival kicked off under the joint sponsorship of the Panzhihua Municipal People's Government ofSichuan Province, China, and the Sichuan Provincial Department of Culture and Tourism. The Joy and S...

2019-12-31 17:04 1792

Gracell to Present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco

SHANGHAI and SUZHOU, China, Dec. 30, 2019 /PRNewswire/ -- Gracell Biotechnologies Co. Ltd., a clinical-stage immune cell therapy company, has announced it will present at leading healthcare conferences inSan Francisco, California at the beginning of January 2020. Gracell will present at the 38th ...

2019-12-30 23:09 1346

Foresee-X Augment Reality Solution from SURGLASSES Is Registered with the FDA and Ready for Trauma Treatment

TAICHUNG, Taiwan, Dec. 30, 2019 /PRNewswire/ -- Foresee-X is a set of smart surgical glasses with functionality based on augmented and mixed reality technologies. This device was developed by SURGLASSES, also known as Taiwan Main Orthopaedic Biotechnology Co. Ltd., and has received IEC60601-1-2 a...

2019-12-30 14:27 1284

Foresee-X Augment Reality Solution from SURGLASSES Is Registered with the FDA and Ready for Trauma Treatment

Oncologie Selected as Top 100 Innovative Pharmaceutical Company in China

SHANGHAI, Dec. 27, 2019 /PRNewswire/ -- Oncologie, a biopharmaceutical company with innovative oncology therapeutics supported by a biomarker platform to select patients, today announced that it has been selected as a Top 100 innovative pharmaceutical company inChina by VCBeat, a renowned healthc...

2019-12-27 21:00 3151

New Major Order From China

STOCKHOLM, Dec. 27, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the fourth quarter of approximatelySEK 16.5 million. "This is the second order from Well Lead outside the initial...

2019-12-27 19:37 1951

Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC

* China NMPA cleared the IND application of BBT-401 submitted on September 25, 2019 * The Phase I clinical study in China will be initiated in May 2020 SEONGNAM, South Korea, Dec. 26, 2019 /PRNewswire/ -- Bridge Biotherapeutics Inc. (KOSDAQ: 288330), a clinical stage biotech company headquart...

2019-12-27 06:30 1757

GenScript and Selecxine Enter Into Strategic Cooperation Agreement

SEOUL, South Korea, Dec. 26, 2019 /PRNewswire/ -- On Dec. 23, 2019, at Seoul, South Korea, the CDMO segment of the world's leading biotech company GenScript announced that it signed a strategic collaboration agreement with Selecxine Inc., a Korean biotech company dedicated to novel therapeutics f...

2019-12-26 22:00 10992

The 13th Dongzhi Ejiao Festival Held in Dong'e County, Shandong Province

DONG'E, China, Dec. 26, 2019 /PRNewswire/ -- On December 22, the 13th Dongzhi Ejiao Festival was held in Ejiao's birthplace, Dong'e County,Shandong Province. It was sponsored by the Herbal Paste Branch of the China Association of Chinese Medicine, the Ejiao Specialty Committee of the China Associ...

2019-12-26 17:51 1569

The 13th Dongzhi Ejiao Festival Held in Dong'e County, Shandong Province

Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development

SHANGHAI, Dec. 25, 2019 /PRNewswire/ -- To seize the ever-changing opportunities in the new era and to meet the ever-growing market demands, the annual gala of the biopharmaceutical industry---bioLIVE China 2020, will be held again at Hall W4 in the SNIEC onJune 22-24, 2020. The exhibition, co-l...

2019-12-25 12:55 2896

Focusing on Cutting-edge Biopharmaceutical Technologies, Boosting the Industry to Achieve Innovation and Development

ALS Awareness Project Led by an ALS Patient

TOKYO, Dec. 24, 2019 /PRNewswire/ -- The END ALS Association (Representative: Motoi Ito, Tokyo, Japan) announced the launch of their Merry & Bright - EEG Illumination project. The objective of this project is to enable Masahiro "Hiro" Fujita,an ALS patient and founder of the association, who has ...

2019-12-24 21:49 1762

ALS Awareness Project Led by an ALS Patient

Viva Biotech Awarded 'Top 10 Public Companies'

BEIJING, Dec. 24, 2019 /PRNewswire/ -- The 'Future Healthcare VB 100 Summit' organized by VCBeat and VCBeat Research was held inBeijing. Viva Biotech was invited to the Summit and awarded the 'Top 10 Public Companies 2019' with honor. Dr. David Xu, the Chief Business Officer of Viva Biotech, was ...

2019-12-24 18:18 1484

EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020

PROVIDENCE, Rhode Island, Dec. 24, 2019 /PRNewswire/ -- EpiVax ("EpiVax, Inc.") continues its record-breaking performance and growth in personnel in 2019 while identifying new milestones to aspire to in 2020. The Business Development team closed 15% more contracts over 2018 and acquired two ne...

2019-12-24 16:35 2086

TOWA PHARMACEUTICAL CO., LTD. reaches an agreement with ESTEVE to acquire ESTEVE's generic division, Pensa Investments

The operation will accelerate TOWA's overseas business presence and provide high-quality and value-added generic medicines to patients. OSAKA, Japan and BARCELONA, Spain, Dec. 23, 2019 /PRNewswire/ -- TOWA PHARMACEUTICAL CO.,LTD. (Osaka, Japan) (TOWA) and ESTEVE (Barcelona, Spain) announced toda...

2019-12-23 17:17 1181

WuXi Biologics Receives "Special Award to Investors in Ireland" from Asia Matters

DUBLIN, Dec. 23, 2019 /PRNewswire/ -- December 23, 2019 – WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, announced that it has received the "Special Awa...

2019-12-23 16:26 2293

Holmusk and NHCS Extend Collaboration to Improve Heart Disease Care

SINGAPORE, Dec. 23, 2019 /PRNewswire/ -- Holmusk and National Heart Centre Singapore announced that they have extended their collaboration agreement to improve care for patients with coronary artery disease using machine learning and data analytics, untilDecember 2020. This will build upon the wo...

2019-12-23 13:43 1923

iView Announces First Patient Treated in Phase 2 Clinical Trial Program Evaluating IVIEW-1201 in Patients with Acute Adenoviral Conjunctivitis

HYDERABAD, India, Dec. 23, 2019 /PRNewswire/ -- iView Therapeutics Inc. today announced that the first patient has been dosed in the Phase 2 IVIEW-1201-01-AIC clinical trial program assessing the efficacy of IVIEW-1201 in patients (age ≥15 years) with Acute Adenoviral Conjunctivitis. First subjec...

2019-12-23 08:42 1862

NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study

LUND, Sweden, Dec. 23, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF) today announced the completed recruitment of healthy volunteers in the second part of the company's ongoing Phase Ia/b clinical study with candidate drug KL1333, in development for chroni...

2019-12-23 08:33 1339

Saluda Medical Results of U.S. Evoke Pivotal Study through 12 Months Published in The Lancet Neurology

Demonstrates Evoke® ECAP-Controlled Closed-Loop SCS Provides Statistically Superior Pain Relief Compared to Open-Loop SCS ARTARMON, Australia, Dec. 20, 2019 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announcedThe Lancet Neurology journal published results from the U.S. P...

2019-12-21 07:48 1737

China's Largest Plasmid and Virus Facility from GenScript was Put into Operation

ZHENJIANG, China, Dec. 20, 2019 /PRNewswire/ -- The CDMO segment of the world's leading biotech company GenScript announced that GenScript's plasmid and virus facility was put into operation onDecember 18, 2019. It is a milestone on the path to industrialization of the gene and cell therapy indus...

2019-12-20 22:00 12926

1 ... 845 846 847848849 850 851 ... 858